About Bevilin Pharma Private Limited
Data last updated:
Bevilin Pharma Private Limited is a private limited company based in Bangalore, Karnataka, India, recognised as a startup by DPIIT. It operates in the manufacturing segment of the chemicals sector. It was incorporated on 11 July 2022.
The company is registered with the Registrar of Companies (ROC), Bangalore, under CIN U24100KA2022PTC163603.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹6 Lakh. It is led by directors including Srinivasa Reddy Ambati and Raghavendrarao Tummalacheruvu.
Its last annual general meeting (AGM) was held on 04 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 156/40/2 1st Cross Layout, Bangalore, Karnataka, India – 560076.
As per the financials filed for FY 2024, the company reported a revenue of ₹83.77 Lakh, reflecting significant growth compared to the previous year. For the same year it recorded a net loss of ₹10,773 (net margin -0.1%) and EBITDA of ₹7,241 (EBITDA margin 0.1%).
For more details, the company can be reached via its website bevilin.com.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered Address156/40/2 1st Cross Layout, Bangalore, Karnataka, India – 560076
- IndustryChemicals, Manufacturing, Basic Chemical
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Bevilin Pharma Private Limited
The main business activity of Bevilin Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Bevilin Pharma Private Limited FY 2024 filings available
Bevilin Pharma Private Limited reported revenue of ₹83.77 Lakh (up 423% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR) of Bevilin Pharma Private Limited
Revenue rose 423% in the latest year. EBITDA rose 100% in the latest year. All are worked out from the filed statements.
Financial Statement Summary of Bevilin Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profit and Loss Statement | ||
| Revenue from Operations | •••• | •••• |
| Other Income | •••• | •••• |
| Total Revenue | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• |
| Employee Benefit Expense | •••• | •••• |
| Finance Costs | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• |
| Other Expenses | •••• | •••• |
| Total Expenses | •••• | •••• |
| EBITDA | ₹7,241 | •••• |
| Profit Before Tax | •••• | •••• |
| Tax Expense | •••• | •••• |
| Net Profit (PAT) | -₹10,773 | •••• |
| Balance Sheet | ||
| Share Capital | •••• | •••• |
| Reserves and Surplus | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• |
| Long-term Borrowings | •••• | •••• |
| Short-term Borrowings | •••• | •••• |
| Trade Payables | •••• | •••• |
| Total Liabilities | •••• | •••• |
| Fixed Assets | •••• | •••• |
| Investments | •••• | •••• |
| Inventories | •••• | •••• |
| Trade Receivables | •••• | •••• |
| Cash and Bank Balance | •••• | •••• |
| Total Assets | •••• | •••• |
Financial Ratios of Bevilin Pharma Private Limited
| Metrics | FY 2023-24 | FY 2022-23 |
|---|---|---|
| Profitability | ||
| EBITDA Margin | 0.1% | •••• |
| Net Profit Margin | -0.1% | •••• |
| Return on Equity (ROE) | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• |
| Liquidity and Debt | ||
| Current Ratio | •••• | •••• |
| Quick Ratio | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• |
| Efficiency and Growth | ||
| Asset Turnover | •••• | •••• |
| Receivable Days | •••• | •••• |
| Payable Days | •••• | •••• |
| Inventory Days | •••• | •••• |
| Revenue Growth | •••• | •••• |
| Net Profit Growth | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Bevilin Pharma are in the company report.
Financial statements from FY 2023
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Peer Comparison of Bevilin Pharma Private Limited
Bevilin Pharma Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Pharma Retail and Distribution). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Lifeway Pharmaceuticals Private Limited | ₹84.16 Lakh (FY 2024) | •••• | •••• | -42.0% | •••• | Hapur, Uttar Pradesh, India |
| Bekem Pharmaceutical Private Limited | ₹84.01 Lakh (FY 2023) | •••• | •••• | 175.0% | •••• | Lucknow, Uttar Pradesh, India |
| Placenta Pharmaceuticals Private Limited | ₹83.98 Lakh (FY 2022) | •••• | •••• | 128.0% | •••• | Chennai, Tamil Nadu, India |
| Evolva Biosciences Private Limited | ₹83.91 Lakh (FY 2024) | •••• | •••• | -21.0% | •••• | Jp Nagar, 8Th Phase, Karnataka, India |
| Reaxzen Healthcare Private Limited | ₹83.88 Lakh (FY 2025) | •••• | •••• | 1.0% | •••• | Hyderabad, Telangana, India |
| Bevilin Pharma Private Limited this company | ₹83.77 Lakh (FY 2024) | •••• | •••• | 423.0% | •••• | Bangalore, Karnataka, India |
| Jydem Bio Pharma Private Limited | ₹83.77 Lakh (FY 2024) | •••• | •••• | 42.0% | •••• | Manimajra, Chandigarh, India |
| Aaltramed Health Care Private Limited | ₹83.72 Lakh (FY 2020) | •••• | •••• | -86.0% | •••• | Hyderabad, Telangana, India |
| Val Polydoors Private Limited | ₹83.71 Lakh (FY 2024) | •••• | •••• | •••• | Hyderabad, Telangana, India | |
| Amay Pharmaceuticals Private Limited | ₹83.65 Lakh (FY 2018) | •••• | •••• | -95.0% | •••• | Ahmedabad, Gujarat, India |
| U P Drug House Private Limited | ₹83.49 Lakh (FY 2021) | •••• | •••• | 160.0% | •••• | Uttar Pradesh, India |
Peers are the five companies nearest above and the five nearest below Bevilin Pharma by revenue in the Pharma industry (Pharma Retail and Distribution), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Board of Directors of Bevilin Pharma Private Limited
Bevilin Pharma has 3 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Srinivasa Reddy Ambati | Director | 11 Jul 2022 | 4 Years 2 Months | Current |
| Raghavendrarao Tummalacheruvu | Director | 11 Jul 2022 | 4 Years 2 Months | Current |
| Jaya Simha Kalavakuri | Director | 21 Mar 2025 | 1 Years 6 Months | Current |
Charges & Borrowings of Bevilin Pharma Private Limited
Bevilin Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Bevilin Pharma Private Limited
Employment history and EPFO contributions of people linked to Bevilin Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Bevilin Pharma Private Limited
Bevilin Pharma Private Limited has 4 board changes on record since 2022: 3 appointments and 1 cessation. The latest: Jaya Simha Kalavakuri was appointed as Director on 21 Mar 2025.
Credit Ratings, Litigation & Regulatory Alerts for Bevilin Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Bevilin Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Bevilin Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Bevilin Pharma Private Limited
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Bevilin Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Bevilin Pharma Private Limited
Bevilin Pharma is an active private limited company based in Bangalore, Karnataka, India. The company works in manufacturing, within the chemicals industry. It was incorporated on 11 July 2022 (4+ years old) and is registered under CIN U24100KA2022PTC163603.
Bevilin Pharma reported revenue of ₹83.77 Lakh for FY 2024 (up 423% YoY).
Bevilin Pharma has 3 current directors:
- Srinivasa Reddy Ambati - Director
- Raghavendrarao Tummalacheruvu - Director
- Jaya Simha Kalavakuri - Director
Bevilin Pharma reported a net loss of ₹10,773 (net margin -0.1%) and EBITDA of ₹7,241 (EBITDA margin 0.1%) for FY 2024, as per its filed financial statements.
The CIN (Corporate Identification Number) of Bevilin Pharma is U24100KA2022PTC163603. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Bevilin Pharma was incorporated on 11 July 2022, making it 4+ years old. It is registered with the Registrar of Companies, Bangalore.
The peers of Bevilin Pharma by revenue are Lifeway Pharmaceuticals Private Limited, Bekem Pharmaceutical Private Limited, Placenta Pharmaceuticals Private Limited, Evolva Biosciences Private Limited, Reaxzen Healthcare Private Limited and 5 more, all in the Pharma industry (Pharma Retail and Distribution).
Jaya Simha Kalavakuri was appointed as Director on 21 Mar 2025. Jhansi Rani Kampa ceased to be Director on 17 Aug 2022. Raghavendrarao Tummalacheruvu was appointed as Director on 11 Jul 2022. Bevilin Pharma has 4 board changes on record in total.
Yes, Bevilin Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Bevilin Pharma can be reached through the website bevilin.com. Its registered office is in Bangalore, Karnataka, India.
The registered office of Bevilin Pharma is at 156402 1st Cross Layout, Bangalore, Karnataka, India – 560076.